A Finite Element Analysis Study from 3D CT to Predict Transcatheter Heart Valve Thrombosis.
image
thrombosis
transcatheter implantation
valve replacement
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
26 Mar 2020
26 Mar 2020
Historique:
received:
25
02
2020
revised:
21
03
2020
accepted:
23
03
2020
entrez:
1
4
2020
pubmed:
1
4
2020
medline:
1
4
2020
Statut:
epublish
Résumé
Transcatheter aortic valve replacement has proved its safety and effectiveness in intermediate- to high-risk and inoperable patients with severe aortic stenosis. However, despite current guideline recommendations, the use of transcatheter aortic valve replacement (TAVR) to treat severe aortic valve stenosis caused by degenerative leaflet thickening and calcification has not been widely adopted in low-risk patients. This reluctance among both cardiac surgeons and cardiologists could be due to concerns regarding clinical and subclinical valve thrombosis. Stent performance alongside increased aortic root and leaflet stresses in surgical bioprostheses has been correlated with complications such as thrombosis, migration and structural valve degeneration. Self-expandable catheter-based aortic valve replacement (Medtronic, Minneapolis, MN, USA), which was received by patients who developed transcatheter heart valve thrombosis, was investigated using high-resolution biomodelling from computed tomography scanning. Calcific blocks were extracted from a 250 CT multi-slice image for precise three-dimensional geometry image reconstruction of the root and leaflets. Distortion of the stent was observed with incomplete cranial and caudal expansion of the device. The incomplete deployment of the stent was evident in the presence of uncrushed refractory bulky calcifications. This resulted in incomplete alignment of the device within the aortic root and potential dislodgment. A Finite Element Analysis (FEA) investigation can anticipate the presence of calcified refractory blocks, the deformation of the prosthetic stent and the development of paravalvular orifice, and it may prevent subclinical and clinical TAVR thrombosis. Here we clearly demonstrate that using exact geometry from high-resolution CT scans in association with FEA allows detection of persistent bulky calcifications that may contribute to thrombus formation after TAVR procedure.
Sections du résumé
BACKGROUND
BACKGROUND
Transcatheter aortic valve replacement has proved its safety and effectiveness in intermediate- to high-risk and inoperable patients with severe aortic stenosis. However, despite current guideline recommendations, the use of transcatheter aortic valve replacement (TAVR) to treat severe aortic valve stenosis caused by degenerative leaflet thickening and calcification has not been widely adopted in low-risk patients. This reluctance among both cardiac surgeons and cardiologists could be due to concerns regarding clinical and subclinical valve thrombosis. Stent performance alongside increased aortic root and leaflet stresses in surgical bioprostheses has been correlated with complications such as thrombosis, migration and structural valve degeneration.
MATERIALS AND METHODS
METHODS
Self-expandable catheter-based aortic valve replacement (Medtronic, Minneapolis, MN, USA), which was received by patients who developed transcatheter heart valve thrombosis, was investigated using high-resolution biomodelling from computed tomography scanning. Calcific blocks were extracted from a 250 CT multi-slice image for precise three-dimensional geometry image reconstruction of the root and leaflets.
RESULTS
RESULTS
Distortion of the stent was observed with incomplete cranial and caudal expansion of the device. The incomplete deployment of the stent was evident in the presence of uncrushed refractory bulky calcifications. This resulted in incomplete alignment of the device within the aortic root and potential dislodgment.
CONCLUSION
CONCLUSIONS
A Finite Element Analysis (FEA) investigation can anticipate the presence of calcified refractory blocks, the deformation of the prosthetic stent and the development of paravalvular orifice, and it may prevent subclinical and clinical TAVR thrombosis. Here we clearly demonstrate that using exact geometry from high-resolution CT scans in association with FEA allows detection of persistent bulky calcifications that may contribute to thrombus formation after TAVR procedure.
Identifiants
pubmed: 32225097
pii: diagnostics10040183
doi: 10.3390/diagnostics10040183
pmc: PMC7235717
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Mech Behav Biomed Mater. 2010 Feb;3(2):167-77
pubmed: 20129416
J Am Coll Cardiol. 2017 Mar 14;69(10):1215-1230
pubmed: 27956264
J Biomech. 2016 Aug 16;49(12):2513-9
pubmed: 26748728
N Engl J Med. 2020 Jan 9;382(2):130-139
pubmed: 31733182
J Thorac Cardiovasc Surg. 2017 May;153(5):1065-1073
pubmed: 28108064
Am J Cardiol. 2018 Jul 1;122(1):141-148
pubmed: 29779587
J Biomech. 2014 Aug 22;47(11):2547-55
pubmed: 24998989
Biomech Model Mechanobiol. 2016 Oct;15(5):1141-57
pubmed: 26603438
Biomech Model Mechanobiol. 2014 Aug;13(4):759-70
pubmed: 24092257
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053
Int J Cardiol. 2015;190:50-2
pubmed: 25912121
J Biomech Eng. 2005 Nov;127(6):905-14
pubmed: 16438226
Circulation. 2002 Dec 10;106(24):3006-8
pubmed: 12473543
J Thorac Cardiovasc Surg. 2015 Apr;149(4):1134-42
pubmed: 25659190
Circulation. 2014 Dec 23;130(25):2332-42
pubmed: 25539521
Circulation. 2000 Aug 15;102(7):813-6
pubmed: 10942752
J Am Coll Cardiol. 2016 Dec 20;68(24):2670-2689
pubmed: 27978952
Lancet. 2017 Jun 17;389(10087):2383-2392
pubmed: 28330690
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
J Am Coll Cardiol. 2019 Jan 8;73(1):13-21
pubmed: 30153483
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
JACC Cardiovasc Interv. 2019 Jan 14;12(1):12-18
pubmed: 30621972
Biomed Res Int. 2018 Oct 22;2018:1346308
pubmed: 30426001
Ann Thorac Surg. 2015 Mar;99(3):831-7
pubmed: 25583467
Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1141-H1149
pubmed: 18621858
JACC Cardiovasc Interv. 2017 Jul 10;10(13):1357-1365
pubmed: 28527771
N Engl J Med. 2014 May 8;370(19):1790-8
pubmed: 24678937
Lancet. 2015 Jun 20;385(9986):2477-84
pubmed: 25788234
Eur Heart J. 2017 Apr 21;38(16):1207-1217
pubmed: 28369242
N Engl J Med. 2015 Nov 19;373(21):2015-24
pubmed: 26436963
J Heart Valve Dis. 1993 May;2(3):326-40
pubmed: 8269128
Ann Biomed Eng. 2010 Aug;38(8):2690-701
pubmed: 20336372
N Engl J Med. 2017 Apr 6;376(14):1321-1331
pubmed: 28304219
Int J Numer Method Biomed Eng. 2017 Apr;33(4):
pubmed: 27274001
EuroIntervention. 2017 Oct 13;13(9):e1067-e1075
pubmed: 28741579
J Thorac Cardiovasc Surg. 2009 Jan;137(1):82-90
pubmed: 19154908
J Thorac Cardiovasc Surg. 2019 Apr;157(4):e149-e151
pubmed: 30901803
J Heart Valve Dis. 2000 Jan;9(1):27-37
pubmed: 10678373
JACC Cardiovasc Interv. 2019 Jan 14;12(1):19-21
pubmed: 30621973
Am Heart J. 2018 Jun;200:44-50
pubmed: 29898848
J Biomed Mater Res A. 2016 Nov;104(11):2785-93
pubmed: 27345614
J Am Coll Cardiol. 2016 Feb 16;67(6):644-655
pubmed: 26868689
J Thorac Cardiovasc Surg. 2016 Jan;151(1):155-64.e1
pubmed: 26602900
J Am Coll Cardiol. 2016 Nov 8;68(19):2059-2069
pubmed: 27580689
Circulation. 2019 Feb 1;:
pubmed: 30704298
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289
pubmed: 28315732